文献速递其他结缔组织病

RUNX3低表达改变系统性硬化症患者树突状细胞功能并促进纤维化

Low RUNX3 expression alters dendritic cell function in patients with systemic sclerosis and contributes to enhanced fibrosis.
PubMed 文献 · Ann Rheum Dis · 2019-05-24

该研究比较了1193例系统性硬化症(SSc)患者与1387名健康供者及8例局限性硬皮病患者的浆细胞样树突状细胞(pDC),发现SSc患者pDC中RUNX3表达下调,与RUNX3基因高甲基化及多态性rs6672420相关,缺氧亦降低RUNX3水平。小鼠中树突状细胞Runx3缺失可自发诱导皮肤纤维化并加重博来霉素诱导的纤维化。

要点

  • SSc患者pDC中转录因子RUNX3表达下调,与基因高甲基化及rs6672420多态性相关。
  • 缺氧是降低pDC中RUNX3水平的另一因素。
  • 树突状细胞Runx3缺失小鼠自发皮肤纤维化并加重博来霉素诱导纤维化。

核心结论

  • SSc患者pDC中RUNX3低表达至少由基因高甲基化和缺氧两条途径导致,Runx3缺失在SSc模型中加重纤维化。

研究设计与样本

  • 比较1193例SSc患者、1387名健康供者和8例局限性硬皮病患者,对分离的pDC进行PCR转录因子谱、甲基化状态、SNP基因分型和流式细胞分析。
  • pDC在缺氧及甲基化抑制剂和缺氧诱导因子抑制剂下培养并测定RUNX3水平。
  • 使用Itgax-Cre:Runx3f/f小鼠进行体外功能实验和博来霉素诱导SSc皮肤炎症与纤维化模型。

主要发现

  • SSc患者pDC中RUNX3表达下调,RUNX3基因高甲基化状态与rs6672420多态性相关,且与较低RUNX3表达及SSc易感性相关。
  • 缺氧是降低pDC中RUNX3水平的另一因素。
  • Runx3缺陷的小鼠pDC在CpG刺激下成熟标志物增强。
  • 树突状细胞中Runx3缺失导致未处理小鼠自发诱导皮肤纤维化,并增加博来霉素诱导皮肤纤维化的严重程度。

临床怎么用

  • RUNX3低表达及RUNX3基因高甲基化可能作为SSc中pDC异常和纤维化风险的潜在生物标志物。
  • 靶向pDC中RUNX3通路或纠正其表观遗传调控可能为SSc纤维化提供治疗思路。

局限性

  • 研究未报告pDC中RUNX3低表达导致纤维化的具体下游机制。
  • 小鼠模型结果外推至人类SSc需进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Systemic sclerosis (SSc) is an autoimmune disease with unknown pathogenesis manifested by inflammation, vasculopathy and fibrosis in skin and internal organs. Type I interferon signature found in SSc propelled us to study plasmacytoid dendritic cells (pDCs) in this disease. We aimed to identify candidate pathways underlying pDC aberrancies in SSc and to validate its function on pDC biology. METHODS: In total, 1193 patients with SSc were compared with 1387 healthy donors and 8 patients with localised scleroderma. PCR-based transcription factor profiling and methylation status analyses, single nucleotide polymorphism genotyping by sequencing and flow cytometry analysis were performed in pDCs isolated from the circulation of healthy controls or patients with SSc. pDCs were also cultured under hypoxia, inhibitors of methylation and hypoxia-inducible factors and runt-related transcription factor 3 (RUNX3) levels were determined. To study Runx3 function, Itgax-Cre:Runx3f/f mice were used in in vitro functional assay and bleomycin-induced SSc skin inflammation and fibrosis model. RESULTS: Here, we show downregulation of transcription factor RUNX3 in SSc pDCs. A higher methylation status of the RUNX3 gene, which is associated with polymorphism rs6672420, correlates with lower RUNX3 expression and SSc susceptibility. Hypoxia is another factor that decreases RUNX3 level in pDC. Mouse pDCs deficient of Runx3 show enhanced maturation markers on CpG stimulation. In vivo, deletion of Runx3 in dendritic cell leads to spontaneous induction of skin fibrosis in untreated mice and increased severity of bleomycin-induced skin fibrosis. CONCLUSIONS: We show at least two pathways potentially causing low RUNX3 level in SSc pDCs, and we demonstrate the detrimental effect of loss of Runx3 in SSc model further underscoring the role of pDCs in this disease.

来源:Ann Rheum Dis,查看原文。版权归原作者所有。

引用

  1. Affandi AJ, Carvalheiro T, Ottria A, et al. Low RUNX3 expression alters dendritic cell function in patients with systemic sclerosis and contributes to enhanced fibrosis. Ann Rheum Dis. 2019. PMID: 31126957. doi:10.1136/annrheumdis-2018-214991

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。